Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37212, USA.
Annu Rev Pharmacol Toxicol. 2010;50:295-322. doi: 10.1146/annurev.pharmtox.011008.145533.
The metabotropic glutamate receptors (mGluRs) are family C G-protein-coupled receptors that participate in the modulation of synaptic transmission and neuronal excitability throughout the central nervous system. The mGluRs bind glutamate within a large extracellular domain and transmit signals through the receptor protein to intracellular signaling partners. A great deal of progress has been made in determining the mechanisms by which mGluRs are activated, proteins with which they interact, and orthosteric and allosteric ligands that can modulate receptor activity. The widespread expression of mGluRs makes these receptors particularly attractive drug targets, and recent studies continue to validate the therapeutic utility of mGluR ligands in neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, anxiety, depression, and schizophrenia.
代谢型谷氨酸受体(mGluRs)属于 C 族 G 蛋白偶联受体,参与中枢神经系统中突触传递和神经元兴奋性的调节。mGluRs 在一个大的细胞外结构域中结合谷氨酸,并通过受体蛋白将信号传递到细胞内信号伙伴。在确定 mGluRs 的激活机制、与其相互作用的蛋白以及能够调节受体活性的变构和正位配体方面已经取得了很大进展。mGluRs 的广泛表达使这些受体成为特别有吸引力的药物靶点,最近的研究继续验证 mGluR 配体在神经和精神疾病(如阿尔茨海默病、帕金森病、焦虑、抑郁和精神分裂症)中的治疗效用。